Skip to main content

Table 2 Multivariate analysis of the four troponin groups and different clinical outcomes (with the following covariates: age, APACHE II, sex, admission diagnosis, diabetes, chronic liver disease, chronic respiratory disease, chronic renal diseases, chronic immunosuppression, vasopressor use, sepsis, cardiac arrest, acute kidney injury, Glasgow Coma Scale, platelet, INR, bilirubin and lactic acid levels)

From: Association between troponin-I levels and outcome in critically ill patients admitted to non-cardiac intensive care unit with high prevalence of cardiovascular risk factors

Variables

Group I

<0.03 ng/ml

N = 649

Group II

0.03–0.3 ng/ml

N = 1572

Group III

0.3– 3 ng/ml

N = 750

Group IV

>3 ng/ml

N = 397

Group II vs Group I

Group III vs Group I

Group IV vs Group I

Categorical variables

aOR (95% CI)

P value

aOR(95% CI)

P value

aOR (95% CI)

P value

 Hospital mortality, N (%)

152 (23.4)

522 (33.2)

372 (49.6)

228 (57.4)

1.08 (0.84,1.38)

0.54

1.64 (1.24, 2.17)

0.0005

1.80 (1.30, 2.49)

0.0004

 Continuous renal replacement therapy, N (%)

35 (5.4)

179 (11.4)

157 (20.9)

95 (23.9)

1.47 (0.95, 2 .26)

0.08

2.12 (1.35, 3.33)

0.001

1.99 (1.21, 3.27)

0.006

 Hemodialysis, N (%)

24 (3.7)

144 (9.2)

86 (11.5)

51 (12.9)

1.73 (1.07, 2.79)

0.02

1.92 (1.15, 3.20)

0.01

1.85 (1.05, 3.26)

0.03

Continuous variables

    

Parameter estimate (95% CI)

 

Parameter estimate (95% CI)

 

Parameter estimate (95% CI)

 

 ICU LOS, days Mean ± SD

7.9 ± 9.1

8.8 ± 11

9.1 ± 10

8.4 ± 20.5

0.87 (-0.23,1.97)

0.12

1.13 (-0.13, 2.40)

0.08

0.48 (-1.02,1.98)

0.53

 Hospital LOS, days Mean ± SD

54.8 ± 82.2

49.6 ± 107.4

40.7 ± 70.8

32.2 ± 182.8

-5.23 (-15.2, 4.7)

0.30

-14.18 (-25.6, 2.7)

0.02

-22.65 (-36.2, 9.1)

0.001

 Mechanical ventilation duration, days, Mean ± SD

6.1 ± 8.3

7.3 ± 10.1

8.2 ± 10.1

8.6 ± 9.3

1.15 (0.26, 2.04)

0.011

2.07 (1.05, 3.09)

<0.0001

2.51 (1.30, 3.73)

<0.0001

  1. aOR adjusted odds ratio